amwell stock price target

Full Answer

Is American well (amwl) stock a buy or sell?

According to the issued ratings of 11 analysts in the last year, the consensus rating for American Well stock is Hold based on the current 6 hold ratings and 5 buy ratings for AMWL. The average twelve-month price target for American Well is $11.75 with a high price target of $18.00 and a low price target of $6.00.

What is the upside for American well's stock?

On average, they expect American Well's stock price to reach $14.00 in the next year. This suggests a possible upside of 124.4% from the stock's current price. View analysts' price targets for American Well or view top-rated stocks among Wall Street analysts.

What will American well's stock price reach in the next year?

Their forecasts range from $6.00 to $29.00. On average, they expect American Well's stock price to reach $14.00 in the next year. This suggests a possible upside of 124.4% from the stock's current price.

What do marketbeat users think about American well stock?

MarketBeat users like American Well stock less than the stock of other Medical companies. 65.85% of MarketBeat users gave American Well an outperform vote while medical companies recieve an average of 67.43% outperform votes by MarketBeat users. Does American Well's stock price have much upside?

Is Amwell a good stock to buy?

Valuation metrics show that American Well Corporation may be overvalued. Its Value Score of F indicates it would be a bad pick for value investors. The financial health and growth prospects of AMWL, demonstrate its potential to underperform the market.

Is AMwell a Buy or Sell?

The consensus among 7 Wall Street analysts covering (NYSE: AMWL) stock is to Buy AMWL stock.

Is American Well a buy?

American Well has received a consensus rating of Buy. The company's average rating score is 2.56, and is based on 5 buy ratings, 4 hold ratings, and no sell ratings.

What is going on with Amwell?

Amwell posted a $229 million net loss for the full year, compared to an $88 million loss in 2019. During the earnings call, Anderson said the company incurred additional expenses in 2020 related to going public in the fall. He noted that Amwell is on track to become profitable.

Will Amwell stock go up?

Based on our forecasts, a long-term increase is expected, the "AMWL" stock price prognosis for 2027-07-05 is 19.236 USD. With a 5-year investment, the revenue is expected to be around +306.67%. Your current $100 investment may be up to $406.67 in 2027. Get It Now!

Why is Amwell stock so low?

The telehealth company, which provides medical consultation to patients, saw tremendous demand for its products and services last year as COVID-19 confined people to their homes to stem the coronavirus spread. Year to date, the stock has lost 59% compared with the industry's decline of 31.7%.

Is hims and hers a good investment?

Hims & Hers is a good investment, it has plenty of potential with growing subscriber numbers and revenue. In addition, it is currently showcasing its plans to expand on a global level with its acquisition of London-based Honest Health.

How is Amwell different from teladoc?

Amwell's EHR integrations allow telehealth to embed into existing clinical workflows and patient portals. Teladoc provides a platform for healthcare professionals across all specialties, including physicians, dermatologists, dietitians, behavioral health, to connect with patients via phone, video, or app.

What company owns teladoc?

The Vanguard Group, Inc. Baillie Gifford & Co. Nikko Asset Management Co., Ltd.

Is MDLive a public company?

MDLive is planning to go public in 2021 following the news of Teladoc-Livongo's mega-deal. But MDLive isn't the only company joining the IPO club, we also expect Doctor on Demand and 98point6 to go public within the next year.

Should I buy or sell American Well stock right now?

9 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for American Well in the last year. There are currently 4 hold rating...

What is American Well's stock price forecast for 2022?

9 brokers have issued 12 month price objectives for American Well's shares. Their forecasts range from $4.00 to $18.00. On average, they predict Am...

How has American Well's stock performed in 2022?

American Well's stock was trading at $6.04 at the beginning of the year. Since then, AMWL shares have decreased by 33.1% and is now trading at $4.0...

Are investors shorting American Well?

American Well saw a decline in short interest during the month of May. As of May 31st, there was short interest totaling 7,790,000 shares, a declin...

When is American Well's next earnings date?

American Well is scheduled to release its next quarterly earnings announcement on Wednesday, August 10th 2022. View our earnings forecast for Amer...

How were American Well's earnings last quarter?

American Well Co. (NYSE:AMWL) posted its quarterly earnings data on Monday, May, 9th. The company reported ($0.26) EPS for the quarter, missing ana...

What guidance has American Well issued on next quarter's earnings?

American Well issued an update on its FY 2022 earnings guidance on Monday, June, 6th. The company provided EPS guidance of for the period. The comp...

Who are American Well's key executives?

American Well's management team includes the following people: Dr. Ido Schoenberg M.D. , Chairman & Co-CEO (Age 57, Pay $1.19M) ( LinkedIn Profi...

Who are some of American Well's key competitors?

Some companies that are related to American Well include Alight (ALIT) , Maximus (MMS) , WNS (WNS) , Shift4 Payments (FOUR) , Farfetch (FTCH)...

How much is American Well's 2021 earnings?

American Well issued an update on its FY 2021 earnings guidance on Tuesday, June, 8th. The company provided earnings per share guidance of $- for the period. The company issued revenue guidance of $260 million-270 million, compared to the consensus revenue estimate of $266.21 million.

How much does American Well make?

American Well has a market capitalization of $2.72 billion and generates $245.26 million in revenue each year. The company earns $-224,430,000.00 in net income (profit) each year or ($2.27) on an earnings per share basis.

Who is the CEO of Amwell?

Amwell®, (NYSE: AMWL) (the "Company") a national telehealth leader, today announced that Ido Schoenberg, Chairman and Co-Chief Executive Officer and Keith Anderson , Chief Financial Officer, will participate in the 42nd Annual Goldman Sachs Global Healthcare Conference including a fireside chat on Wednesday, June 9, 2021 at 9:40 a.m. ET.

What are the stocks that could post underwhelming results in the months ahead?

Three stocks that could post underwhelming results in the months ahead include American Well (NYSE: AMWL), Amazon (NASDAQ: AMZN), and Target (NYSE: TGT).

2 Growth Stocks That Are Trading Below Their IPO Prices

Are these stocks too cheap to pass up or are they destined for more declines?

Amwell to Report Fourth Quarter and Full Year 2021 Operating Results and Host Conference Call on Thursday, February 2..

BOSTON-- (BUSINESS WIRE)--Amwell®, (NYSE: AMWL) (the "Company") a national telehealth leader, today announced that it will report fourth quarter and full year ended December 31, 2021 operating results on...

Christie Campus Health Adds SilverCloud Health to Mental Health Services Platform for College Students

LEXINGTON, Mass., Jan. 13, 2022 /PRNewswire/ -- One of the nation's leading providers of mental health services for college students has announced that it is partnering with another leader in the space ...

2 Disappointing Stocks in 2021 That Could Be Hot Buys Next Year

Both Amwell and Alibaba have been struggling mightily this year, down more than 40%.

Amwell to Report Third Quarter 2021 Operating Results and Host Conference Call on Wednesday, November 10, 2021

BOSTON-- (BUSINESS WIRE)--Amwell®, (NYSE: AMWL) (the "Company") a national telehealth leader, today announced that it will report third quarter ended September 30, 2021, operating results on Wednesday, N...

Amwell's Converge Virtual Care Platform Hailed as Best New Application in Telehealth

BOSTON-- (BUSINESS WIRE)--Amwell's Converge Platform wins recognition from UCSF, Chilmark Research and MassTLC as it moves into general availability

The Clinic by Cleveland Clinic and RubiconMD Announce Partnership to Advance Access to Specialty Expertise

CLEVELAND & NEW YORK-- (BUSINESS WIRE)--The Clinic by Cleveland Clinic™, a joint venture between Cleveland Clinic and Amwell® (NYSE: AMWL), and RubiconMD, a leader in virtual-first specialty care solutio...

Stock Price Forecast

The 11 analysts offering 12-month price forecasts for American Well Corp have a median target of 8.00, with a high estimate of 12.00 and a low estimate of 6.00. The median estimate represents a +98.02% increase from the last price of 4.04.

Analyst Recommendations

The current consensus among 15 polled investment analysts is to Hold stock in American Well Corp. This rating has held steady since February, when it was unchanged from a Hold rating. Move your mouse over past months for detail